Cipla Share Price

Cipla

CMP as on 24-May-22 11:42

₹ 974.00
3.95 0.41%

Open

₹ 977.00

Turnover (lac)

₹ 7,871

Prev. Close

₹ 970.05

Day's Vol (shares)

₹ 8,08,125

Day's Range (₹)

₹ 961.75
₹ 977.70

CMP as on24-May-22 11:42

₹ 974.10
3.55 0.37%

Open

₹ 975.00

Turnover (lac)

₹ 940

Prev. Close

₹ 970.55

Day's Vol (shares)

₹ 16,189

Day's Range

₹ 962.00
₹ 977.10

CMP as on 24-May-22 11:42

₹ 971.85
-5.25 -0.54%

Open

₹ 969.10

Open Interest(Contracts)

₹ 81,17,200

VWAP

₹ 970.86

Day's Vol (shares)

₹ 22,45,100

Day's Range (Ex.Dt. 26 May 2022)

₹ 961.90
₹ 977.35

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 19-Apr-2022 - -
CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2022 inter alia to consider and approve This is to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday 10th May 2022 inter-alia to consider and approve the audited standalone and consolidated financial results for the quarter and year ended 31st March 2022 and recommendation of dividend if any. In compliance with the provision of the Companys Code of Conduct for Prevention of Insider Trading the Trading Window for dealing in the securities of the Company has been closed from Friday 1st April 2022 up to Thursday 12th May 2022 (both days inclusive). In furtherance to our intimation dated 10th May, 2022 under Regulation 30 and 33 of the SEBI (Listing Obligations Requirements) Regulations, 2015, the meeting of the Board of Directors which commenced today at 2.30 p.m. (IST) has concluded at 6.40 p.m. (IST). Please find enclosed letter dated 10th May 2022 In furtherance to our intimation dated 10th May, 2022 under Regulation 30 and 33 of the SEBI (Listing Obligations Requirements) Regulations, 2015, the meeting of the Board of Directors which commenced today at 2.30 p.m. (IST) has concluded at 6.40 p.m. (IST). We wish to inform you that, the Board of Directors of the Company at its meeting held on 10th May 2022 has approved the changes in the Key Managerial Personnel (KMPs) authorized under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) with effect from 10th May 2022. The contact details of the KMPs authorized under Regulation 30(5) of the Listing Regulations are enclosed. (As Per NSE Announcement Dated on 10/05/2022)
Board Meeting - 30-Dec-2021 - -
Quarterly Results In furtherance to our intimation dated 25th January 2022 under Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, w.r.t the unaudited financial results (standalone and consolidated) for the quarter and nine months ended 31st December, 2021, approved by the Board of Directors at its meeting held today, we hereby notify that the said Board meeting of the Company which commenced today at 2.30 p.m. (IST) has concluded at 6.35 p.m. (IST). Pursuant to the provisions of Regulation 30 of the SEBI Listing Regulations and further to the intimation dated 26th October 2021, we hereby notify that the Board of Directors of Cipla Limited (the Company) at its meeting held today, i.e., 25th January, 2022 have inter alia, approved the transfer of the following undertakings as a going concern on a slump sale basis in the following manner: (i) India based US business undertaking (Undertaking 1) to Cipla BioTec Limited, a wholly owned subsidiary of the Company (Transferee Company 1 or CBL); and (ii) Consumer business undertaking (Undertaking 2) to Cipla Health Limited, wholly owned subsidiary of the Company (Transferee 2 or CHL) as a going concern on a slump sale basis. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the following: i. Unaudited financial results (standalone and consolidated) as per Indian Accounting Standards for the quarter and nine months ended 31st December, 2021 as approved by the Board at its meeting held on 25th January, 2022; ii. Limited review report (standalone and consolidated) by Walker Chandiok & Co LLP, Statutory Auditor of the Company, for the quarter and nine months ended 31st December, 2021. The meeting of the Board of Directors of the Company commenced at 02.30 p.m. (IST) and is still in progress. (As per BSE Announcement Dated on 25/01/2022)
Board Meeting - 01-Oct-2021 - -
Quarterly Results Please find enclosed letter dated 26 October 2021 (As per BSE Announcement Dated on 26/10/2021)
Board Meeting - 26-Jul-2021 - -
Quarterly Results CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2021 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 5th August, 2021 inter-alia to consider and approve unaudited standalone and consolidated financial results for the quarter ended 30th June, 2021. In terms of the Companys Code of Conduct for Prevention of Insider Trading, for the purposes of financial results, the Trading Window for dealing in the securities of the Company has been closed from 1st July, 2021 till 7th August, 2021. Please find enclosed letter dated 30th June 2021. (As Per BSE Announcement dated on 05.08.2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity